Skip to Content

CYPAR MILK THISTLE CAPSULES

Active substance(s): MILK THISTLE DRY EXTRACT

View full screen / Print PDF » Download PDF ⇩
Transcript
a company of

Certification
Mark

Patient Information Leaflet

Cypar

®

Milk Thistle Capsules

Mockup GB 01P0615 151 3811/01

capsules
Milk thistle standardised fruit extract

Read all of this leaflet carefully before you start
taking this medicine because it contains important information for you.
Always take this medicine exactly as described in this
leaflet or as your doctor or pharmacist has told you.
Keep this leaflet. You may need to read it again.
Ask your pharmacist if you need more information or
advice.
If you get any side effects, talk to your doctor or phar­
macist. This includes any possible side effects not list­
ed in this leaflet. See section 4.
You must talk to a doctor or qualified healthcare prac­
titioner if you feel worse, or if you do not feel better af­
ter 1 week.
1

Bezeichnung:

GI Cypar® Milk Thistle Capsules

Größe:

Inhalt:

30 Kapseln

Material:

Artikel-Nr.:

566113

Teile-Nr.:

Mockup

Druck-Kennz.:

01P0615

Laetus-Code:

(151)

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

What is in this leaflet
1. What Cypar ® Milk Thistle is and what it is used for
2. What you need to know before you take Cypar ® Milk
Thistle
3. How to take Cypar ® Milk Thistle
4. Possible side effects
5. How to store Cypar ® Milk Thistle
6. Contents of the pack and other information
1. What Cypar® Milk Thistle is and what it is used for
This product is a traditional herbal medicinal product
containing milk thistle standardised fruit extract.
Cypar ®  Milk Thistle Capsules is a traditional her­bal
medicinal product used to relieve the symptoms
­associated with occasional overindulgence of food
and drink such as indigestion and upset stomach
based on traditional use only.
2. What you need to know before you take
Cypar® Milk Thistle
Do not take Cypar ® Milk Thistle if
– You are pregnant or breastfeeding
– You are allergic to any of the ingredients or to
plants of the Asteraceae/Compositae family such
as daisies, marigolds or artichokes (see section 6)
– You are under 18 years of age
Tell your doctor before taking this product if you are
currently suffering from active liver disease.

If you take more Cypar® Milk Thistle than you should
If you take more than the recommended dose, speak
to a doctor, pharmacist or qualified healthcare prac­
titioner and take this leaflet with you.
If you forget to take Cypar® Milk Thistle
Continue to take your usual dose at the usual time, it
does not matter if you have missed a dose.
If you have any questions, or are unsure about any­
thing, please ask your doctor, pharmacist or qualified
healthcare practitioner.
4. Possible side effects
Like all medicines, this product can cause side effects,
although not everybody gets them.
The following side effects have been reported:
– Dry mouth, nausea (feeling sick), upset stomach,
gastric irritation such as bloated feeling, burning
sensation after eating, diarrhoea and headache
If these persist for more than a few days or ­become
more troublesome, stop taking the ­product. The side
effects are usually only temporary.

2

3

45 °

– allergic reactions such as dermatitis, itching and/or
skin rash, urticaria, hives, pruritus, asthma and an­
aphylaxis - a severe allergic reaction causing diffi­
culty in breathing, shortness of breath and requires

Lackaussparung:

Datum: 04.10.2016 Versions-Nr.: 00-4

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Andreas Ueberschär

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

You must talk to a doctor or qualified healthcare
practitioner if you feel worse, or if you do not feel
­
­better after 1 week.

3. How to take Cypar® Milk Thistle
Always take this medicine exactly as your doctor or
pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.
Adults and the elderly.
Take one capsule up to twice daily. Swallow the
capsule whole with some water or other liquid.
­
­Capsules should not be chewed.

210 x 148 mm

Schwarz

Do not exceed the stated dose.
Do not give this product to children or adolescents
under 18 years old.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 1 von 2

medical attention. If you experience an allergic re­
action stop taking the product immediately.
The frequency is not known (frequency cannot be esti­
mated from the available data).
Reporting of side effects
If you get any side effects, talk to your doctor or phar­
macist. This includes any possible side effects not
­listed in this leaflet. You can also report side effects
directly via the Yellow Card Scheme, Website:
www.mhra.gov.uk/yellowcard. By reporting side
­effects you can help provide more information on the
safety of this medicine.
5. How to store Cypar® Milk Thistle
Do not use your capsules after the expiry date. The ex­
piry date refers to the last day of that month.
The expiry date is printed on the box and the blister
pack.

Mockup GB 01P0615 151 3811/01

Do not throw away any medicines via wastewater or
household waste. Ask your pharmacist how to throw
away medicines you no longer use. These measures
will help to protect the environment.
Do not store above 25° C.
Store in original package.
Keep your capsules out of the sight and reach of
children.
Keep your capsules in the blister pack until it is time to
take them.

4

6. Contents of the pack and other information
What Cypar® Milk Thistle contains
The active substance is 193 mg – 261 mg of standard­
ised extract (as dry extract) from milk thistle fruits
­(Silybum marianum (L.) Gaertner) (equivalent to
3.725 g – 10.818 g of milk thistle fruits). This amount of
standardised extract corresponds to 108 mg of
silymarin, calculated as silibinin. Extraction solvent:
­
Acetone 95 % v/v.

Traditional herbal registration number:
THR 29860/0007

The other ingredients are:
Extract excipient:
Mannitol
Capsule contents:
Mannitol, cellulose microcrystalline, crosscarmellose
sodium, silica colloidal anhydrous, magnesium stea­
rate.
Capsule shell:
Gelatin, purified water, titanium dioxide (E 
171),
sodium laurylsulfate, iron (III)-oxide (E 172) (red iron
oxide), iron oxide hydrate (E 172) (yellow iron oxide).

Telephone: 01202 780558
Fax: 01202 780559
Email.: info@ceutahealthcare.com

GI Cypar® Milk Thistle Capsules

Größe:

Inhalt:

30 Kapseln

Material:

Artikel-Nr.:

566113

Teile-Nr.:

Mockup

Druck-Kennz.:

01P0615

Laetus-Code:

(151)

EAN-Code:

Druckfarbe/
Winkelung bei
einer
Rasterweite
von 150 lpi

Manufacturer
Klosterfrau Berlin GmbH
Motzener Strasse 41
12277 Berlin
Germany

Cassella-med GmbH is a company of the

6

45 °

Lackaussparung:

Datum: 04.10.2016 Versions-Nr.: 00-4

Sachbearbeiter G+G

Verwendete Schriften:

I)-

Prüfung und Freigabe Köln:

Andreas Ueberschär

VAG Rounded

II)-

q Frei

überprüft durch:

Helvetica

III)-

Andreas Ueberschär
q Neuer Abzug erforderlich
Prüfung und Freigabe Berlin:
q Frei

PZN-Code:
Land:

For a large print, Braille or audio version
of this leaflet, call Ceuta Healthcare Ltd.
on 08006527150

Traditional Herbal Registration Holder
Cassella-med GmbH & Co.KG
Gereonsmuehlengasse 1
50670 Cologne
Germany

210 x 148 mm

Schwarz

This leaflet was last revised in July 2016

Each pack contains 30 or 60 hard capsules. The cap­
sules are red opaque.

5

Bezeichnung:

If you would like further information about this
product, please contact:
Ceuta Healthcare Ltd.,
41 Richmond Hill,
BOURNEMOUTH BH2 6HS,
United Kingdom.

Geprüft durch PPC:
q Ja

q Nein

EAN lesbar:
England

q Neuer Abzug erforderlich

q Ja

q Nein

Seite: 2 von 2

Expand view ⇕

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide